Preconception Counseling and Care in the Setting of HIV: Clinical Characteristics and Comorbidities
Table 2
Clinical characteristics of HIV-infected women, HIV-infected men, and HIV-affected couples.
HIV infected women ()
HIV infected men ()
HIV serodiscordant couples ()
HIV seroconcordant couples ()
F
M
F
M
Either
F
M
Years living with HIV
87
28
55
20
75
21
8
.51
Mean (SD)
7 (5.7)
6.1 (6.1)
7 (5.8)
4.9 (4.4)
—
8 (6.4)
9 (87.7)
CD4 count, cells/mm3
83
28
56
18
74
21
10
.18
<200
5 (4)
11 (3)
7 (4)
5 (1)
7 (5)
0 (0)
20 (2)
200–499
46 (38)
64 (18)
39 (22)
67 (12)
46 (34)
60 (12)
60 (6)
500
49 (41)
25 (7)
54 (30)
28 (5)
47 (35)
40 (8)
20 (2)
CD4 nadir, cells/mm3
76
18
50
16
66
21
2
.06
<200
49 (37)
56 (10)
42 (21)
50 (8)
44 (29)
67 (14)
100 (2)
≥200
51 (39)
44 (8)
58 (29)
50 (8)
56 (37)
33 (7)
0 (0)
Plasma viral load, copies/mL
81
31
54
19
73
21
12
.07
<75
70 (57)
84 (26)
65 (35)
79 (15)
68 (50)
86 (18)
92 (11)
75–999
9 (7)
6.5 (2)
13 (7)
5 (1)
11 (8)
0 (0)
8 (1)
1,000–9,999
9 (7)
3 (1)
13 (7)
5 (1)
11 (8)
0 (0)
0 (0)
≥10,000
12 (10)
6.5 (2)
9 (5)
11 (2)
10 (7)
14 (3)
0 (0)
Undetectable plasma viral load (<75 copies/mL)
81
31
54
19
73
21
12
.09
Yes
70 (57)
84 (26)
65 (35)
79 (15)
68 (50)
86 (18)
92 (11)
No
30 (24)
16 (5)
35 (19)
21 (4)
32 (23)
14 (3)
8 (1)
Antiretroviral therapy
87
38
56
20
76
23
18
.76
Currently on ART
80.5 (70)
89 (34)
79 (43)
90 (18)
80 (61)
84 (19)
89 (16)
Efavirenz regimen#
23 (16)
—
21 (9)
—
—
26 (5)
—
—
Data in table are % () unless otherwise stated. Denominator for each variable () is listed due to missing data. SD: standard deviation; ART: antiretroviral therapy; —: n/a; F: female patient; M: male patient. Wilcoxon rank sum test was used for comparison of means, and Fisher’s exact or Pearson chi square was used for comparisons of categorical variables among women in serodiscordant versus seroconcordant relationships.
#Efavirenz regimen percentage is limited to women who are taking ART.
